Advertisement
News
Subscribe to MDT Magazine News

FDA Reviews DNA-Based Colon Cancer Screening Kits

March 28, 2014 4:23 pm | by Matthew Perrone, AP Health Writer | Comments

The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests which use patients' DNA to detect dangerous tumors and growths. FDA scientists have questions about the accuracy and the...

TOPICS:

Demand for Home Medical Equipment to Approach $13 Billion in 2018

March 28, 2014 3:02 pm | by The Freedonia Group | Comments

U.S. demand for home medical equipment will increase 8.2 percent annually to $12.6 billion in 2018. According to analyst Bill Martineau, “Advances in the technological capabilities of products, coupled with ongoing health care cost containment...

TOPICS:

FDA Approval of Abbott’s Supera Stent for Peripheral Artery Disease

March 28, 2014 2:37 pm | by Abbott | Comments

Abbott today announced that its Supera Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD). PAD occurs...

TOPICS:
Advertisement

Sober Smartphone App Aids Alcoholics’ Recovery

March 28, 2014 2:21 pm | by Lindsey Tanner, AP Medical Writer | Comments

A smartphone app for recovering alcoholics that includes a panic button and sounds an alert when they get too close to taverns helped keep some on the wagon, researchers who developed the tool found. The sober app studied joins a host of...

TOPICS:

Baxter Splitting into Two Separate Businesses

March 28, 2014 2:09 pm | by Linda A. Johnson, AP Business Writer | Comments

Following a rival's lead, Baxter International Inc. said it's planning a breakup into two health care companies as it tries to boost innovation and profitability and reward shareholders. Thursday's news could mark a recent trend as Wall...

TOPICS:

Abbott Announces FDA Approval of Its Supera Stent to Treat People with Peripheral Artery Disease

March 28, 2014 12:36 pm | by The Associated Press | Comments

Abbott has announced that its Supera Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD). PAD occurs when...

TOPICS:

Photos of the Day: Watson vs. Brain Cancer (Infographic)

March 28, 2014 11:20 am | by IBM | Comments

IBM and NYGC's computational biology experts are renowned for accelerating life sciences discoveries using deep analytical approaches and next generation information technologies. The system, expected to be deployed as a cloud-based...  

TOPICS:

IBM’s Watson Takes on Brain Cancer

March 28, 2014 11:17 am | by IBM | Comments

New York Genome Center (NYGC) and IBM are collaborating to analyze genetic data to accelerate the race to personalized, life-saving treatment for brain cancer patients. IBM's Watson cognitive computing system will be designed to analyze the...

TOPICS:
Advertisement

Committee Developing Proposed Standard for Unicondylar Knee Joint Replacements

March 28, 2014 10:45 am | by ASTM International | Comments

A proposed new ASTM International standard will cover fatigue testing of metallic tibial trays, which are components used in partial knee joint replacement. ASTM WK45235, Practice for Cyclic Fatigue Testing of Metal Tibial Tray Components...

TOPICS:

World's First Pacemaker Series with Event-Triggered IEGM Transmissions Gains CE Mark

March 28, 2014 10:40 am | by PresseBox | Comments

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series today. The new generation of pacemakers includes single and dual-chamber as well as cardiac resynchronization...

TOPICS:

CAN Calls on DoJ to Investigate J&J for Document Destruction

March 28, 2014 10:17 am | by Corporate Action Network | Comments

The Corporate Action Network (CAN) has filed a complaint with the Department of Justice (DOJ) against Johnson and Johnson and its top executives, including Chairman and CEO Alex Gorsky for destroying documents critical to lawsuits brought...

TOPICS:

Biomarkers Predict Effectiveness of Radiation Treatments

March 27, 2014 4:11 pm | by Beaumont Research | Comments

An international team of researchers, led by Beaumont Health System’s Jan Akervall, M.D., Ph.D., looked at biomarkers to determine the effectiveness of radiation treatments for patients with squamous cell cancer of the head and neck. They identified two markers that ...

TOPICS:

Clemson Researcher Touts Surgical Safety Checklist to Save Lives

March 27, 2014 4:07 pm | by Clemson University | Comments

Clemson University research assistant professor Ashley Kay Childers has been selected to participate in a forum to discuss quality improvement programs in U.S. hospitals that reduce preventable readmissions, prevent medical errors, improve patient outcomes and ...

TOPICS:

Using PET Scanning to Evaluate Therapies of Menkes Disease

March 27, 2014 4:03 pm | by Satoshi Nozaki, RIKEN | Comments

Researchers at the RIKEN Center for Life Science Technologies in Japan have used PET imaging to visualize the distribution in the body of copper, which is deregulated in Menkes disease, a genetic disorder, using a mouse model. This study lays the groundwork for PET imaging studies on ...

TOPICS:

Anti-Clotting Agent Helps Reduce the Incidence and Impact of Stent Thrombosis

March 27, 2014 4:00 pm | by Judy Romero, Cardiovascular Research Foundation | Comments

A new angiographic analysis of the CHAMPION PHOENIX trial examined the incidence and impact of stent thrombosis (ST) in patients undergoing percutaneous coronary intervention (PCI). CHAMPION PHOENIX was a prospective, double-blind, active-controlled trial which ...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading